ライフサイエンスコーパス: cytology

1 undetermined significance (hereafter ASC-US cytology).

2 by flow cytometry with multiple markers, and cytology.

3 Rs of primary HPV screening were relative to cytology.

4 women underwent HRA following abnormal anal cytology.

5 e HIV-infected women were screened with anal cytology.

6 idence of precursor lesions detected by anal cytology.

7 al disease more accurately than conventional cytology.

8 ctival epithelium was obtained by impression cytology.

9 sociations in vitro, and characterized their cytology.

10 creening algorithm were higher than those of cytology.

11 by eyelid margin and conjunctival impression cytology.

12 ne HPV DNA status, HPV 16/18 serostatus, and cytology.

13 enotyping alone and in combination with anal cytology.

14 nts with atypical, negative or indeterminate cytology.

15 ing, "enriched" with 300 women with abnormal cytology.

16 t invasive cervical carcinomas compared with cytology.

17 r syndrome (DTS) via conjunctival impression cytology.

18 ne was high and was associated with abnormal cytology.

19 fied epithelium and thus mirrored changes in cytology.

20 avoiding unnecessary fine needle aspiration cytologies.

21 l cancer in HIV-negative women (PR vs normal cytology 14.1, 11.1-17.9, p<0.0001).

22 pants with negative baseline results of anal cytology, 37% developed abnormal cytology findings (inci

23 a family member due to death) with abnormal cytology (390,310 first abnormal and 1,951,319 normal sm

24 ly higher (83.6%, 95% CI 71.9-91.8) than for cytology (62.3%, 95% CI 49.0-74.4) (p=0.005).

25 ly higher (83.6%; 95% CI, 71.9-91.8) than of cytology (62.3%; 95% CI, 49.0-74.4; P = 0.005).

26 igen (61%; 95% CI, 46% to 74%; P < .001) and cytology (84%; 95% CI, 71% to 92%; P = .02).

27 C): frozen section = 86%, 96%, 0.96 (n = 9); cytology = 91%, 95%, 0.98 (n = 11); intraoperative ultra

28 Cervical cytology abnormality following either HPV vaccination or

29 aphics, clinical characteristics, and sputum cytology after sputum induction were examined.

30 Confocal microscopy and impression cytology agreement in testing the diagnostic hypotheses

31 posite endpoint comprising anal liquid-based cytology (aLBC) and high-risk human papillomavirus (HR-H

32 ardless of sample collection before or after cytology aliquoting.

33 ompared to 4/21 cases identified by positive cytology alone.

34 patients that were difficult to diagnose by cytology alone.

35 oVysion probes (45.9%) (P < .001) or routine cytology analysis (18.8%) (P < .001), but similar specif

36 rformance with that of UroVysion and routine cytology analysis.

37 All had anal cytology and a high-resolution anoscopy at baseline.

38 r secondary prevention in triaging low-grade cytology and as a test of cure after treatment.

39 We next review the cytology and cell biology of the multiple-fission cell c

40 Cytology and cobas and LA HPV testing were conducted for

41 tential to be used in conjunction with urine cytology and cystoscopy to improve clinical diagnosis of

42 edle aspiration include performing cyst wall cytology and DNA analysis.

43 Clinic; results were available from routine cytology and FISH with UroVysion probes.

44 tiveness included rates of abnormal cervical cytology and genital warts.

45 evaluate the additional prognostic impact of cytology and growth pattern and to improve risk stratifi

46 Using the Ki-67 index is superior to using cytology and growth pattern as prognostic factors in MCL

47 underwent high-resolution anoscopy and anal cytology and had anal and cervical samples collected.

48 In men who have sex with men undergoing anal cytology and high-resolution anoscopy, we measured respo

49 type brain tumor patients, preserving tumor cytology and histoarchitecture in all specimens.

50 PV genotypes and anal disease prevalence, by cytology and histopathologic findings, were evaluated am

51 A combination of anal cytology and HPV genotyping provided the highest accurac

52 DVICE 4: Clinicians may use a combination of cytology and HPV testing once every 5 years in average-r

53 In this observational study, all cervical cytology and HPV testing reports from January 1, 2007, t

54 ervical cells from sexually active women for cytology and HPV testing.

55 Anal cytology and HPV-16 genotyping had the best screening pe

56 Abnormal anal cytology and HPV-16 infection performed best as a screen

57 Anal swab specimens were collected for cytology and human papillomavirus (HPV) testing.

58 We used a combination of genetic analyses, cytology and immunolocalisation to define the function o

59 lymphadenopathy; the tumor shows high-grade cytology and lacks both BCL2 expression and t(14;18) tra

60 genitalium and its association with cervical cytology and other correlates, we recruited 350 female s

61 Limitations of biliary cytology and other diagnostic studies have driven the de

62 the cancer burden, the Indian Institute for Cytology and Preventive Oncology, in collaboration with

63 Our objective was to measure cytology and proteome of vaginal swab samples taken on p

64 Changes in cytology and proteome over the first two weeks after bir

65 Using cytology and RAD-seq, we show that C. biroi reproduces v

66 ervical-exfoliation samples for conventional cytology and sexually transmitted infection (STI) testin

67 screening, we used the SurePath liquid-based cytology and the BD Onclarity HPV Assay.

68 images from biological samples (e.g., fixed cytology and tissue sections, live cells or biofluids) t

69 f which were verified pathologically, 111 by cytology and/or during follow-up (at least 24 months).

70 espectively 77.8% for automated, 60-100% for cytology, and 80% for immunostaining based enumeration.

71 e Ki-67 index by using published guidelines, cytology, and growth pattern.

72 th a high-grade colposcopic impression, HSIL cytology, and human papillomavirus (HPV) type 16 positiv

73 ogy for the management of low grade abnormal cytology, and in a test of cure.

74 s and has found its way into histopathology, cytology, and microbiology.

75 dels (OA and OPOA), and conducted histology, cytology, and molecular analyses.

76 e 3-month ureteroscopic evaluation, negative cytology, and negative for-cause biopsy.

77 e mutation panel was performed for nonbenign cytology, and positive MT results indicated initial TT.

78 multiple anogenital HPV infections, abnormal cytology, and seropositivity for cutaneous HPVs.

79 multiple anogenital HPV infections, abnormal cytology, and seropositivity to nongenital HPVs.

80 of keratitis is based on visual exam, tissue cytology, and standard microbial culturing to determine

81 ficity for CCA, outperforming standard brush cytology, and suggest that the biomarker panel, potentia

82 men, the difference in referral rate between cytology- and HPV-screened women was not significant.

83 CSF cultures and cytology are infrequently positive.

84 or control doses, had negative or low-grade cytology at baseline, and had no history of HPV disease.

85 ts in conjunctival cells taken by impression cytology at each visit.

86 mary endpoint, cervical HSIL by histology or cytology at either week 26 or 52, was compared between a

87 assigned to HPV-based (experimental arm) or cytology-based (control arm) screening in Sweden (Swedes

88 eening for cervical cancer was compared with cytology-based cervical screening, and precursors of can

89 of the relative efficacy of HPV-based versus cytology-based screening for prevention of invasive canc

90 th diagnosis and death of 11%, compared with cytology-based screening in unvaccinated cohorts.

91 Compared with cytology-based screening, HPV screening is predicted to

92 countries are considering transitioning from cytology-based to HPV-based cervical screening.

93 inated at older age (>/= 18) or had abnormal cytology before vaccination.

94 Cervical cytology between July 2007 and July 2014 was tested with

95 o HPV 6, 11, 16, and 18 and rate of abnormal cytology between perinatally HIV-infected (PHIV) and per

96 Established cytology biobanks, typically collected with a cytobrush,

97 The posterior vagina was swabbed using a cytology brush on PND 0, 2 and 16 and slides were prepar

98 eral other HPV types for women with abnormal cytology but not for those with normal cytology, suggest

99 lial neoplasia grade 2+ [CIN2+]) compared to cytology, but no evaluation has been conducted in a popu

100 ong those >/= 18 with no history of abnormal cytology, but there was no evidence of protection among

101 ction follow-up who had HR-HPV screening and cytology by Papanicolaou smear performed yearly between

102 (AUS) after NAC after fine-needle aspiration cytology can identify abnormal nodes and guide patient s

103 mined aggressive disease in 1 false negative cytology case and confirmed a negative cytology diagnosi

104 Of the 9 atypical cytology cases, MP correctly diagnosed 7 as positive and

105 w-up (chi2 = 22.9; P < .0001), (iv) abnormal cytology (chi2 = 9.8; P = .0017), and (v) concomitant pr

106 Assessment of 4,056 cytology collections by Cervista HPV HR and APTIMA HPV y

107 d significantly increased sensitivity versus cytology, comparing regression vs. persistence/progressi

108 Cytology correctly diagnosed aggressive disease in 4 pat

109 fluid was collected at 24, 96, and 144 h for cytology, cytokine quantification, and flow cytometry.

110 ncer at age 21 years once every 3 years with cytology (cytologic tests without human papillomavirus [

111 ine clinical data included anal and cervical cytology, demographic/behavioral data, and high-resoluti

112 sy with PV associated nephropathy, any urine cytology demonstrating "decoy" cells, and/or significant

113 The worst-ever cytology diagnosis and the 4-year cumulative proportions

114 ative cytology case and confirmed a negative cytology diagnosis in 7 of 7 cases of non-aggressive dis

115 Phenotypes of asthma based on the sputum cytology did not differ between the groups.

116 However, FNA cytology does not allow differentiation between follicul

117 4 years, underwent a baseline CXR and sputum cytology examination and received five screening rounds

118 lts of anal cytology, 37% developed abnormal cytology findings (incidence rate, 13.9 cases/100 person

119 The incidence of abnormal anal cytology findings was high and more likely to develop am

120 sent a pragmatic approach to address biliary cytology findings when encountered in PSC.

121 multifaceted approach that involves biliary cytology, FISH, serologic testing and advanced imaging t

122 r with ultrasound and fine-needle aspiration cytology (FNA).

123 equire ultrasound and Fine Needle Aspiration Cytology (FNAC) evaluation.

124 The sensitivity and specificity of urine cytology for detecting UC were 73.9% and 94.7%, respecti

125 ry (FCM) is more sensitive than conventional cytology for detection of occult leptomeningeal lymphoma

126 n addition, data about the accuracy of urine cytology for the detection and the role of the BK virus

127 ervical screening, as an adjunct to cervical cytology for the management of low grade abnormal cytolo

128 score and Ki-67 index in pleural biopsies or cytologies from 123 patients (69 lung cancer, 25 mesothe

129 m women who underwent AC screening with anal cytology from April 2009 to July 2014 were analyzed.

130 k sonographic characteristics plus follow-up cytology from fine-needle aspiration can identify thyroi

131 ypes as well as their prevalence in abnormal cytology (from ASCUS to cervical cancer) among Mexican w

132 oma cell lines that we established exhibited cytology, genomics, mRNA, and protein profiles that were

133 on in young women and in those with abnormal cytology, greater heterogeneity was seen in older women

134 risk HPV (HR-HPV) vaccine types and abnormal cytology has not been well characterized.

135 ancer screening or triage of mildly abnormal cytology, has recently been demonstrated.

136 Pooled data suggest that frozen section and cytology have the greatest diagnostic accuracy.

137 ritoneal deposits and/or positive peritoneal cytology) have an extremely poor prognosis.

138 itized C57Bl/6 mice were studied by means of cytology, histology, real-time PCR, and ELISA.

139 In 2 of 7 patients with cytology/histology available at primary diagnosis and at

140 ples from the endometrium were collected for cytology, histopathology, carbohydrate analysis, and exp

141 t least 2 years, compared with negative anal cytology; however, the high positivity of HR-HPV in HIV+

142 When cytology, HPV16/18 and HPV16/18/31/33 genotyping, and th

143 When cytology, HPV16/18- and HPV16/18/31/33-genotyping, and S

144 ked in 14 patients with positive staple line cytology (HR, 0.22; P = .24).

145 nadjusted and adjusted Poisson regression of cytology (HSIL) and histopathology (CIN2, CIN3, and CIN2

146 Impression cytology (IC) was taken from the bulbar conjunctiva of t

147 ng confocal microscopy (LSCM) and impression cytology (IC).

148 ultrasound examinations and reassessment of cytology if significant growth is observed.

149 te-specific antigen, serum creatinine, urine cytology, imaging, cystourethroscopy, post-void residual

150 e Linear Array HPV genotyping assay (LA) and cytology in HIV-infected MSM.

151 mend routine anal cancer screening with anal cytology in persons living with human immunodeficiency v

152 e enforced bacterial culture in the nose and cytology in the nasal smear in asymptomatic (PreAs), sym

153 nant biliary strictures with routine biliary cytology in this population is challenging.

154 r of additional tests required (e.g., reflex cytology) in women where underlying CIN2+ is extremely u

155 de precancerous cervical lesions compared to cytology, in a population where high vaccine uptake was

156 a 4% to 9% increased risk for first abnormal cytology, in situ and invasive cervical cancer (all P <

157 lation testing was approved as an adjunct to cytology, in Taiwan, and is now undergoing registration

158 Oral exfoliative cytology is a diagnostic method that involves the study

159 Cytology is a less invasive method to assess oral potent

160 Exfoliative cytology is a simple technique that may be used to detec

161 Anal cytology is easy to perform routinely; it may be the bes

162 The sensitivity of CSF cytology is low (2%-32%) but increases when combined wit

163 PV 16/18 to triage women with minor abnormal cytology is poorly sensitive but may be useful as a seco

164 PV 16/18 to triage women with minor abnormal cytology is poorly sensitive but may be useful as a seco

165 Therefore, noninvasive urine cytology is usually used in the clinic as an adjunct to

166 lying cervical atypia missed by conventional cytology, it is limited by a spatial resolution of ~3 mu

167 re 2 (HC2) HPV test (Qiagen) to liquid-based cytology (LBC) for women undergoing routine cervical scr

168 ity was assessed in BD SurePath liquid-based cytology (LBC) medium (SurePath) using contrived panels

169 HPV screening versus 2.5-yearly liquid-based cytology (LBC) screening.

170 d LBC screening with HPV triage of low-grade cytology ('LBC screening'), (ii) HPV screening with thos

171 SSA/Ps with cytology markers of dysplasia were associated with a par

172 ing factors; additionally, findings based on cytology may not generalise to human papillomavirus test

173 p Pap test vial containing PreservCyt liquid cytology medium, and tested in a blinded fashion with co

174 in the context of biofluid, histopathology, cytology, microbiology, and biomarker discovery framewor

175 average-risk women for cervical cancer with cytology more often than once every 3 years.

176 When used in conjunction with first line cytology, MP increased detection of aggressive disease w

177 mination (n = 22) and/or positive peritoneal cytology (n = 11) without other organ metastasis were en

178 women with Hybrid Capture 2 (HC2)-positive, cytology-negative results and who were age >/=30 years f

179 en with human papillomavirus (HPV)-positive, cytology-negative results is critical to the introductio

180 of CIN3+ among all women with HC2-positive, cytology-negative results was 4.6%.

181 ealthy, with no history of abnormal cervical cytology, no previous abnormal cervical biopsy results,

182 We demonstrate that cytology normal HPV+ and HPV- samples contain DNAm patte

183 present evidence that DNAm patterns exist in cytology normal HPV- samples that (i) predispose to neop

184 Cytology-normal/HPV-positive women were invited for repe

185 Abnormal cytology occurred in 33 of 56 PHIV and 1 of 7 PHEU sexua

186 e existence of connections is related to the cytology of cortical areas, in addition to the role of p

187 Impression cytology of the lower eyelid margin and tarsal conjuncti

188 These results pave the way for "spectral" cytology of urine using Raman microspectroscopy.

189 Thirty-nine percent had abnormal anal cytology on initial screen and 15% on secondary screen;

190 [CIN3+]) and also found it earlier than did cytology or cotesting.

191 Currently surgeons rely on touch preparation cytology or frozen section analysis to assess tumour mar

192 tatic carcinoma of the pancreas confirmed by cytology or histology.

193 CIN at the resection margins; were tested by cytology or HPV assay between 3 months and 9 months afte

194 sed by histology or immunohistochemistry and cytology or immunocytology.

195 VICE 7: Clinicians should not obtain urinary cytology or other urine-based molecular markers for blad

196 ening for the early detection of UC by urine cytology or periodic sonographic surveys is mandatory, e

197 imaging (P < .001), cancer cells by routine cytology (overall P = .003), as well as absence of prima

198 35% and 50% for carcinoembryonic antigen and cytology ( P < .001 and P = .003, respectively).

199 Greater relative reductions in abnormal cytology (P < 0.001) were observed for HPV-vaccinated wo

200 igh accuracy is presented using liquid-based cytology Pap smears.

201 replication in all kidney biopsies and urine cytologies performed between 1998 and 2014 from kidney t

202 SB and TB impression cytology performed on control eyes, Sjogren syndrome (SS

203 e cytology results or 2 consecutive negative cytology plus HPV test results within 10 years, with the

204 seen in older women and in those with normal cytology, possibly reflecting greater variability in exp

205 sed cytological specimens, namely, automated cytology processing and glacial acetic acid (GAA) treatm

206 y trial were aliquoted prior to or following cytology processing and tested for HPV.

207 negative result following routine automated cytology processing, despite close proximity to known-po

208 ndent of GAA treatment and routine automated cytology processing.

209 sed in a consecutive fashion by an automated cytology processor without fastidious decontamination pr

210 In a cytology-proven VRL case, all 15 vitreous isolated B cel

211 results were obtained from the pathology or cytology reports.

212 The detection rate for an abnormal cervical cytology result during the observation period was lower

213 red for colposcopy because of a cervical Pap cytology result of atypical squamous cells of undetermin

214 The risk for an abnormal cervical cytology result was lower among vaccinated vs unvaccinat

215 ics, clinic type, abnormal baseline cervical cytology result, and baseline Chlamydia screening (as pr

216 Women with normal cytology results and positive hrHPV results were also re

217 ncer if they have had 3 consecutive negative cytology results or 2 consecutive negative cytology plus

218 Controls were women who had normal cytology results over two subsequent screening rounds at

219 2008 and 2012, and 20677 (4.5%) of the first cytology results per woman were reported as ASC-US.

220 When first line malignant (positive) cytology results were combined with positive second line

221 Cytology results were examined in a total of 30 patients

222 When first line cytology results were uncertain (atypical), questionable

223 modal diagnostic models were developed using cytology results, lesion characteristics, and risk facto

224 cine effectiveness against abnormal cervical cytology results.

225 ine the strengths and limitations of biliary cytology, review the application of other techniques to

226 Five enucleated globes and 1 cytology sample from a patient with Coats' disease and 1

227 Conjunctival impression cytology samples collected from participants before the

228 erase chain reaction analysis of whole-brush cytology samples from patients with IgG4-related cholang

229 performed a retrospective analysis of 3,518 cytology samples from round 1 ARTISTIC enriched for unde

230 oplasia (CIN2+) in a total of 8,610 cervical cytology samples from the ARTISTIC population-based cerv

231 We collected residual liquid-based cytology samples from US women aged 20-29 years who were

232 BECs isolated from the brush cytology samples revealed decreased levels of claudin-1

233 Forty-nine (65%) anal cytology samples were abnormal, and 38 (51%) of anal sam

234 Thirty-six percent of HC2-positive normal cytology samples were HR HPV negative by both PapilloChe

235 IN2+ detection rates for HPV-screened versus cytology-screened women in Australia's HPV-vaccinated po

236 V-screened group were 41%-44% higher than in cytology-screened women, the difference in referral rate

237 Cytology screening during the detectable preclinical pha

238 We estimate that cervical cytology screening of all women aged 55-79 years in the

239 lower in persons with HIV engaged in an anal cytology screening program.

240 in HIV-infected subjects engaged in an anal cytology screening program.

241 sought to quantify the efficacy of cervical cytology screening to reduce death from this disease.

242 ars of age and underwent subsequent cervical cytology screening.

243 With both the S5 classifier and cytology set at a specificity of 38.6% (95% confidence i

244 ates of human papillomavirus (HPV) triage of cytology showing atypical squamous cells of undetermined

245 MP of DNA from microdissected cytology slides and from discarded supernatant fluid was

246 al profiling (MP) of DNA from microdissected cytology slides and supernatant specimens may play in th

247 olunteers without lesions and obtained brush cytology specimens and matched scalpel biopsies from 486

248 s and assessed the potential value of liquid cytology specimens for predicting STIs.

249 n-based stratified sample of 59 664 cervical cytology specimens from women residing in New Mexico wer

250 nferior bulbar (IB) and temporal bulbar (TB) cytology specimens stained for MUC5AC revealed a signifi

251 e, and Trichomonas vaginalis in liquid-based cytology specimens were 1.5, 2.1, 0.6, and 4.4%, respect

252 Brush cytology specimens were analyzed by machine learning cla

253 Tear washes and conjunctival impression cytology specimens were collected through standard proce

254 fluorescence in situ hybridization on brush cytology specimens, from two time points with a median i

255 cobas can be used for HPV detection in anal cytology specimens.

256 Molecular testing of the >=4-cm AUS and FN cytology subcategory impacted neoplasm discovery (combin

257 ormal cytology but not for those with normal cytology, suggesting that type replacement in women vacc

258 Screening for cervical cancer with cytology testing has been very effective in reducing cer

259 With both S5 and cytology tests set at a specificity of 38.6% (95% CI 28.

260 en were recruited and tested by liquid-based cytology, the HC2 assay, and the AHPV assay.

261 ibility of retrograde ejaculation with urine cytology, the results of which were negative.

262 sures included: bronchoalveolar lavage fluid cytology to assess airway eosinophilia, pulmonary mechan

263 her HR types, and associations with abnormal cytology to assess potential vaccine impact.

264 opic ultrasound with cyst fluid analysis and cytology to confirm the type of cyst and determine the r

265 Here we employ genetics, biochemistry and cytology to dissect the role of the linker in FtsZ funct

266 ultrasonography, and fine-needle aspiration cytology to identify 38 patients who received 4 cycles o

267 this notable gap, we used immunofluorescent cytology to quantify genome-wide recombination rates in

268 nodules >=4-cm, including those with benign cytology, to identify follicular adenoma.

269 confocal microscopy, conjunctival impression cytology, tonometry and fundus exam.

270 referred to colposcopy and with dual-stained cytology triage for OHR types ('HPV+DS triage').

271 IV-negative women (from 1% [5/498] in normal cytology up to 22% [59/273] in cervical HSIL; PR 23.1, 9

272 Cyclic changes in vaginal cytology, uterine histology, serum hormone levels, and w

273 Prevalence of abnormal anal cytology was 12.9% (95% CI, 9.2%-17.7%; 6 studies includ

274 ections; the prevalence of abnormal cervical cytology was 38% among women who were HR HPV-positive co

275 Protection against abnormal cytology was also diminished in sexually active PHIV fem

276 Blastoid cytology was associated with inferior OS independently o

277 One specimen that was indeterminate by cytology was correctly diagnosed as non-aggressive by MP

278 Among 61 MSW, abnormal anal cytology was detected in 12 (20%) and was associated wit

279 Among 299 MSM, abnormal cytology was detected in 161 (54%) MSM and was associate

280 g findings, US-guided fine-needle aspiration cytology was performed to confirm the diagnosis, and app

281 Pleural fluid cytology was positive for adenocarcinoma.

282 Cytology was then correlated with histopathology in enuc

283 gin-to-tumor ratio < 1, positive staple line cytology, wedge resection, nodule size > 2.0 cm), SRB di

284 Women with abnormal cytology were managed according to the routine recommend

285 Colposcopic directed biopsies and cervical cytology were performed at week 26 and 52.

286 rval) for HR-HPV to predict hHSILs in normal cytology were positive predictive value (PPV), 29.3% (25

287 Women with abnormal cytology were referred to colposcopy, biopsy, and treatm

288 howed significantly increased sensitivity vs cytology when comparing regression vs persistence/progre

289 with a combination of the S5 classifier and cytology, whereas HPV genotyping did not provide additio

290 ression outcome with a combination of S5 and cytology, whereas HPV16/18 or HPV16/18/31/33-genotyping

291 pecific interactions among women with normal cytology, which they consider an indication that type re

292 nodules >=4-cm, including those with benign cytology, which was not explained by available molecular

293 able to identify patients with indeterminate cytology who can confidently be followed without surgery

294 of all patients (N = 671) with nonmalignant cytology who had thyroidectomy between October 2010 and

295 gnificance/follicular or oncocytic neoplasm) cytology who received initial lobectomy were 2.5 times m

296 An integrative analysis combining cytology with genomic and transcriptomic data reveals bi

297 morphological changes that are identified by cytology with hematoxylin and eosin staining but also pr

298 We evaluated the association of cytology with HRA results, and predictors of HSIL pathol

299 To examine 5-year outcomes after ASC-US cytology with vs without HPV testing.

300 d 24 nodules with indeterminate preoperative cytology, with accuracies of 93% and 89%.